Abstract
Seven-transmembrane (7TM) receptors are one of the most important proteins involved in perception of extracellular stimuli and regulation of variety of intracellular signaling pathways. Divergence of receptor types, their ligands and signaling pathways makes 7TM receptors important factors in pathology of many diseases. This review focused on the main diseases in which involvement of 7TM receptors was established e.g., retinitis pigmentosa, severe obesity, and dwarfism. Recent findings of aberrant expression of 7TM receptors in development of cancer were also summarized.
Publisher
Uniwersytet Lodzki (University of Lodz)
Reference57 articles.
1. Abdulaev, N.G. 2003. Building a stage for interhelical play in rhodopsin. Trends Biochem. Sci. 28: 399–402.
2. Arora, P., Ricks, T.K., Trejo, J. 2007. Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer. J. Cell Sci. 120: 921–928.
3. Balistreri, C.R., Caruso, C., Grimaldi, M.P., Listi, F., Vasto, S., Orlando, V., Campagna, A.M., Lio, D., Candore, G. 2007. CCR5 receptor: biologic and genetic implications in age-related diseases. Ann. N. Y. Acad. Sci. 1100: 162–172.
4. Barak, L.S., Oakley, R.H., Laporte, S.A., Caron, M.G. 2001. Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proc. Natl. Acad. Sci. U. S. A 98: 93–98.
5. Barzon, L., Pacenti, M., Masi, G., Stefani, A.L., Fincati, K., Palu, G. 2005. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors. Oncology 68: 414–421.